Data Insights
Leading innovators in attenuated virus-based vaccines for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of new treatment...
Leading innovators in CKD treatment compositions for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of new treatment...
Q2 2024 update: cybersecurity related hiring actvity in the pharma industry
The global pharmaceutical industry experienced a 7% drop in new job postings related to cybersecurity in Q2 2024 compared with...
Q2 2024 update: corporate governance related hiring actvity in the pharma industry
The global pharmaceutical industry experienced a 9% rise in new job postings related to corporate governance in Q2 2024 compared...
Q2 2024 update: artificial intelligence related hiring actvity in the pharma industry
The global pharmaceutical industry experienced a 10% rise in new job postings related to artificial intelligence in Q2 2024 compared...
Genomics: the leading companies in genetic engineered T-cells revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of new treatment...
Q4 2023 update: private equity deals in pharmaceutical in Europe
In the European pharmaceutical industry, there were 21 private equity deals announced in Q4 2023, worth a total value of...
Most active FDI companies in the healthcare industry
C is the healthcare company most prolific at making international expansions, followed by Takeda Pharmaceutical and Fresenius SE & Co....
The role of FDI in the healthcare industry
The US is the leading destination market for greenfield healthcare FDI, while Australia is the top source market. GlobalData’s healthcare...
Q4 2023 update: patent activity in the pharmaceutical industry
The global pharmaceutical industry experienced 0% rise in patent filings in Q4 2023 compared with the previous quarter. The total...
How did the pharmaceutical industry treat cybersecurity in Q4 2023 filings?
The global pharmaceutical industry experienced a 15% drop in company filings mentions of cybersecurity in Q4 2023 compared with the...
How did the pharmaceutical industry treat environmental sustainability in Q4 2023 filings?
The global pharmaceutical industry experienced a 21% drop in company filings mentions of environmental sustainability in Q4 2023 compared with...
Q4 2023 update: mentions of corporate governance in pharmaceutical industry filings
The global pharmaceutical industry experienced a 34% drop in company filings mentions of corporate governance in Q4 2023 compared with...
Q4 2023 update: mentions of social responsibility in pharmaceutical industry filings
The global pharmaceutical industry experienced a 35% drop in company filings mentions of social responsibility in Q4 2023 compared with...
Q4 2023 update: mentions of artificial intelligence in pharmaceutical industry filings
The global pharmaceutical industry experienced an 11% rise in company filings mentions of artificial intelligence in Q4 2023 compared with...
Q4 2023 update: mentions of COVID-19 in pharmaceutical industry filings
The global pharmaceutical industry experienced a 69% drop in company filings mentions of COVID-19 in Q4 2023 compared with the...
Q4 2023 update: mentions of big data in pharmaceutical industry filings
The global pharmaceutical industry experienced a 21% drop in company filings mentions of big data in Q4 2023 compared with...
Q4 2023 update: mentions of blockchain in pharmaceutical industry filings
The global pharmaceutical industry experienced a 69% drop in company filings mentions of blockchain in Q4 2023 compared with the...
How did the pharmaceutical industry treat future of work in Q4 2023 filings?
The global pharmaceutical industry experienced a 16% drop in company filings mentions of future of work in Q4 2023 compared...
How did the pharmaceutical industry treat orphan designated drugs in Q4 2023 filings?
The global pharmaceutical industry experienced a 5% rise in company filings mentions of orphan designated drugs in Q4 2023 compared...